Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Grant and collaboration revenues	$ 715,977	$ 364,232
Operating expenses:
Research and development	808,936	555,718
General and administrative	502,345	510,064
Total operating expenses	1,311,281	1,065,782
Loss from operations	(595,304)	(701,550)
Other income (expense):
Interest income	752	1,224
Interest expense	(1,142)	(1,128)
Total other income (expense)	(390)	96
Net loss	$ (595,694)	$ (701,454)
Basic and diluted:
Net loss per common share (in dollars per share)	$ (0.13)	$ (2,851.44)
Weighted average shares outstanding (in shares)	4,687,893	246